The currently available anti-cancer therapies, such as gamma-radiation and
chemotherapeutic agents, induce cell death and cellular senescence not only in cancer cells …

Breast cancer is a common malignancy threatening women's health around the world.
Despite improved treatments for different subtypes of breast tumors that have been put …

Introduction: Although there have been significant advances in research and treatments over
the past decades, cancer remains a leading cause of morbidity and mortality, mostly due to …

The extremely low frequency electromagnetic field (ELF-EMF) is emerging as a novel
approach in cancer treatment. This study evaluated the impact of daily exposure to 50 Hz …

Thirteen million cancer deaths and 21.7 million new cancer cases are expected in the world
by 2030. Glioblastoma is the most common primary malignant tumor of the central nervous …

Methods: A triple-positive mouse breast cancer cell line (MC4L2) was purchased from the
Genetic Resource Center (Iran). This study was performed on two groups of ELF-EMF …

Introduction A common drawback of many anticancer therapies is non-specificity in action of
killing. We investigated the potential of ultra-low intensity and frequency pulsed …

Abstract Aims and Background: Tumor diseases cause 20% of deaths in Europe and they
are the second most common cause of death and morbidity after cardiovascular diseases …

Background The exposure of breast cancer to extremely low frequency magnetic fields (ELF-
MFs) results in various biological responses. Some studies have suggested a possible …

Extremely low-frequency electromagnetic fields (ELF-MF) can modify the cell viability and
regulatory processes of some cell types, including breast cancer cells. Breast cancer is a …